Activated monocyte

Activated monocytes are circulating leukocytes from the innate immune system that become functionally primed upon pathogen exposure or inflammatory signals, migrating to tissues to differentiate into macrophages or dendritic cells. They perform phagocytosis of microbes and debris, antigen presentation to T cells, and cytokine secretion (e.g., IL-10, TNF-α) to orchestrate immune responses.[1][3][5] In disease, they drive inflammation in conditions like multiple sclerosis, atherosclerosis, and cancer by infiltrating tissues and polarizing into pro- or anti-tumorigenic states, with subsets like Cxcl10+ monocytes exacerbating autoimmunity.[2][4][7] Therapeutically, they are targeted via CCR2 inhibition to block recruitment, PD-L1 modulation for tolerance, or CD40 agonists combined with checkpoint inhibitors to enhance anti-tumor immunity, as seen in clinical trials for solid tumors.[2][4] Challenges include balancing pro- and anti-inflammatory functions to avoid excessive immunosuppression or cytokine storms.[1][2]

Other names

Activated macrophage precursorinflammatory monocytepro-inflammatory monocyte

CCR2 blockade to inhibit recruitment, PD-L1 induction for immunosuppression, CD40 agonism to enhance antigen presentation and PD-L1 expression, cytokine modulation (e.g., IL-12 for activation, IL-10 for anti-inflammation), polarization to M2-like anti-inflammatory phenotype